Investment Firm
Overview
Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.
Nov 30, 2022
Series A
Highlights
Location
Social
Participant Investors
1
Investor Name |
---|
General Catalyst |
Vial raised $34000000 on 2022-11-30 in Series A
Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.
Company Funding History
3
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Nov 30, 2022 | Series B - Vial | 13 | - | 67.0M |
Nov 30, 2022 | Series A - Vial | 2 | - | 34.0M |
Apr 15, 2021 | Seed Round - Vial | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.